Profile
Tetsuya Mishima is currently the Representative Director at Anaeropharma Science, Inc. He previously held positions as Director at CellGenTech, Inc. and Partner at Watervein Partners KK.
Prior to his current and former positions, he worked as a Principal at Bank of America Corp.
Mishima received his undergraduate and graduate degrees from Tokyo Institute of Technology.
Tetsuya Mishima active positions
| Companies | Position | Start |
|---|---|---|
Anaeropharma Science, Inc.
Anaeropharma Science, Inc. BiotechnologyHealth Technology Engages in research and development of novel therapeutics and anti-cancer drugs | Director/Board Member | - |
Watervein Partners KK
Watervein Partners KK Investment ManagersFinance Watervein Partners is an active manager which provides financing for seed stage capital requirements. The firm targets companies operating in the field of life science. It invests in companies located in Japan. | Private Equity Investor | 2002-08-31 |
CellGenTech, Inc.
CellGenTech, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development of drugs for new gene therapy and regenerative medicine | Director/Board Member | 2004-12-31 |
Former positions of Tetsuya Mishima
| Companies | Position | End |
|---|---|---|
| BANK OF AMERICA CORPORATION | Corporate Officer/Principal | - |
Training of Tetsuya Mishima
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Bank of America Corp.
Bank of America Corp. Major BanksFinance Operates as a bank holding company whose subsidiaries provides consumer and global banking, markets brokerage & wealth and investment management services | Finance |
Tokyo Institute of Technology
Tokyo Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anaeropharma Science, Inc.
Anaeropharma Science, Inc. BiotechnologyHealth Technology Engages in research and development of novel therapeutics and anti-cancer drugs | Health Technology |
Watervein Partners KK
Watervein Partners KK Investment ManagersFinance Watervein Partners is an active manager which provides financing for seed stage capital requirements. The firm targets companies operating in the field of life science. It invests in companies located in Japan. | Finance |
CellGenTech, Inc.
CellGenTech, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development of drugs for new gene therapy and regenerative medicine | Health Technology |
- Stock Market
- Insiders
- Tetsuya Mishima
















